#ASH25: Early in vivo CAR-T results like Kelonia's elicit excitement across the field
#ASH25：早期体内CAR-T结果（如Kelonia Therapeutics的进展）引发全行业兴奋

ORLANDO, Fla. — A single, ready-made infusion got rid of any detectable cancer cells in four multiple myeloma patients in Australia, Kelonia Therapeutics reported as part of its first clinical trial readout.
佛罗里达州奥兰多——在Kelonia Therapeutics首次临床试验披露的结果中，澳大利亚有四名multiple myeloma患者在一次即用型输注后未检出任何可检测的癌细胞。